Pregabalin + Diphenhydramine
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Lumbar Spinal Stenosis
Conditions
Lumbar Spinal Stenosis
Trial Timeline
Mar 1, 2008 → Sep 1, 2010
NCT ID
NCT00638443About Pregabalin + Diphenhydramine
Pregabalin + Diphenhydramine is a approved stage product being developed by Pfizer for Lumbar Spinal Stenosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00638443. Target conditions include Lumbar Spinal Stenosis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00638443 | Approved | Completed |
Competing Products
4 competing products in Lumbar Spinal Stenosis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| teriparatide + Placebo | Eli Lilly | Approved | 85 |
| BG00010 IV + BG00010 SC + Placebo IV + Placebo SC | Biogen | Phase 1 | 30 |
| BG00010 + Placebo | Biogen | Phase 2 | 49 |
| BRTX-100 + Saline | BioRestorative Therapies | Phase 2 | 44 |